Clinical Trial Update: Eswatini Ring Study: Increasing PrEP Options for Women

View source ↗

Summary

The Eswatini Ring Study, sponsored by FHI 360, investigating PrEP options for HIV prevention in women, has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: FHI 360 | Conditions: HIV Prevention | Status: TERMINATED